Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: Evidence from squirrel monkeys responding under a schedule of food presentation

Psychopharmacology

Volumn 227, Issue 2, 2013, Pages 347-354

  Fischer, Bradford D ^a,b   Teixeira, Laura P ^a   Van Linn, Michael L ^c   Namjoshi, Ojas A ^c   Cook, James M ^c   Rowlett, James K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Rowan University ^*  (United States)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Benzodiazepine; GABAA receptors; Operant behavior; Physical dependence; Withdrawal

Indexed keywords

3 PROPOXY BETA CARBOLINE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 8 ETHYNYL 6 (2' PYRIDINE) 4H 2,5,10B TRIAZA BENZO[E]AZULENE 3 CARBOXYLIC ACID ETHYL ESTER; BENZODIAZEPINE DERIVATIVE; BETA CARBOLINE 3 CARBOXYLIC ACID TERT BUTYL ESTER; CHLORDIAZEPOXIDE; FLUMAZENIL; HZ 166; UNCLASSIFIED DRUG; ZOLPIDEM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG RESPONSE; INSTRUMENTAL CONDITIONING; LIGHT DARK CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SQUIRREL MONKEY;

ANIMALS; BENZODIAZEPINES; CHLORDIAZEPOXIDE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUMAZENIL; FOOD; GABA ANTAGONISTS; GABA MODULATORS; IMIDAZOLES; PYRIDINES; RECEPTORS, GABA-A; REINFORCEMENT SCHEDULE; SAIMIRI; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 84879601998     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-2975-2     Document Type: Article

References (38)

1. Adams JU, Holtzman SG (1990) Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats. J Pharmacol Exp Ther 253:483-489
2. A receptors, is a nonsedating anxiolytic in rodents and primates. J Pharmacol Exp Ther 316:410-422
3. Bronson ME (1994) Chlordiazepoxide, but not bretazenil, produces acute dependence, as evidenced by disruptions in schedule-controlled behavior. Pharmacol Biochem Behav 48:397-401
4. A receptor. J Neurosci 22:5572-5580
5. A receptors. Proc Natl Acad Sci U S A 99:8980-8985
6. Elliot EE, White JM (2000) Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem. Pharmacol Biochem Behav 66:361-369
7. Fischer BD, Licata SC, Edwankar RV, Wang ZJ, Huang S, He X, Yu J, Zhou H, Johnson EM Jr, Cook JM, Furtmüller R, Ramerstorfer J, Sieghart W, Roth BL, Majumder S, Rowlett JK (2010) Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure. Neuropharmacology 59:612-618
8. Gerak LR, France CP (1997) Repeated administration of flumazenil does not alter its potency in modifying schedule-controlled behavior in chlordiazepoxide treated rhesus monkeys. Psychopharmacology 131:64-70
9. Griffiths RR, Weerts EM (1997) Benzodiazepine self-administration in humans and laboratory animals - implications for problems of long-term use and abuse. Psychopharmacology 134:1-37
10. Griffiths RR, Sannerud CA, Ator NA, Brady JV (1992) Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. J Pharmacol Exp Ther 260:1199-1208
11. A receptor alpha1 subtype in the ventral pallidum regulates alcohol-seeking behaviors. J Neurosci 22:3765-3775
12. Holm KJ, Goa KL (2000) Zolpidem: an update of its pharmacology, therapeutic efficacity and tolerability in the treatment of insomnia. Drugs 59:865-889
13. Holtzman SG, Villarreal JE (1973) Operant behavior in the morphine-dependent rhesus monkey. J Pharmacol Exp Ther 184:528-541
14. Kliethermes CL, Metten P, Belknap JK, Buck KJ, Crabbe JC (2004) Selection for pentobarbital withdrawal severity: correlated differences in withdrawal from other sedative drugs. Brain Res 1009:17-25
15. A receptor subtypes. Nature 451:330-334
16. A receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4- (pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one]. J Pharmacol Exp Ther 313:1118-1125
17. A receptor modulation and beyond. Pharmacol Biochem Behav 90:74-89
18. Löw K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, Bluethmann H, Mohler H, Rudolph U (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131-134
19. Lukas SE, Griffiths RR (1982) Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro 15-1788) after 7 days of diazepam. Science 217:1161-1163
20. Lukas SE, Griffiths RR (1984) Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure. Eur J Pharmacol 100:163-171
21. A receptor α1 subtype. Nat Neurosci 3:587-592
22. McMahon LR, France CP (2002) Daily treatment with diazepam differentially modifies sensitivity to the effects of gamma-aminobutyric acid(A) modulators on schedule-controlled responding in rhesus monkeys. J Pharmacol Exp Ther 300:1017-1025
23. Mirza NR, Nielsen EØ (2006) Do subtype-selective gamma-aminobutyric acid A receptor modulators have a reduced propensity to induce physical dependence in mice? J Pharmacol Exp Ther 316:1378-1385
24. Olsen RW, Sieghart W (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev 60:243-260
25. Paronis CA, Bergman J (1999) Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys. J Pharmacol Exp Ther 290:1222-1229
26. Perrault G, Morel E, Sanger DJ, Zivkovic B (1992) Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. J Pharmacol Exp Ther 263:298-303
27. Platt DM, Carey G, Spealman RD (2011). Models of neurological disease (substance abuse): self-administration in monkeys. Curr Protoc Pharmacol. Chapter 10:Unit10.5
28. A-benzodiazepine receptors produced in transfected cells. Science 245:1389-1392
29. A receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc Natl Acad Sci U S A 102:915-920
30. Rudolph U, Crestani F, Benke D, Brunig I, Benson JA, Fritschy JM, Martin JR, Bluethmann H, Mohler H (1999) Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401:796-800
31. A receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol Sci 22:188-194
32. A receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats? Prog Neuropsychopharmacol Biol Psychiatry 34:376-386
33. A receptors determined using 36Cl ion flux. Mol Pharmacol 59:1108-1118
34. Spealman RD (1986) Disruption of schedule-controlled behavior by Ro 15-1788 one day after acute treatment with benzodiazepines. Psychopharmacology 88:398-400
35. Tan KR, Brown M, Labouèbe G, Yvon C, Creton C, Fritschy JM, Rudolph U, Lüscher C (2010) Neural bases for addictive properties of benzodiazepines. Nature 463:769-774
36. Vanover KE, Robledo S, Huber M, Carter RB (1999) Pharmacological evaluation of a modified conflict procedure: punished drinking in non-water-deprived rats. Psychopharmacology (Berl) 145:333-341
37. Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P (2007) Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol 64:198-209
38. Weerts EM, Griffiths RR (1998) Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons. Behav Pharmacol 9:285-297